GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Exam Corner/Nasogastric Tubes in 2026: Use Them Selectively, Remove Them Early: JAMA Surgery August | 2026.
3

Nasogastric Tubes in 2026: Use Them Selectively, Remove Them Early: JAMA Surgery August | 2026.

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated August 1, 2026

Key Takeaways

NG tubes remain most valuable for decompression, particularly in small-bowel obstruction (SBO), severe gastric distension, vomiting, ileus, or impaired gastrointestinal propulsion.

Why decompression works: the gastrointestinal tract normally handles several litres of secretions daily.

Obstruction/ileus → impaired forward flow and absorption → fluid accumulation → bowel distension, vomiting and aspiration risk → NG decompression reduces intraluminal volume and pressure.

In uncomplicated adhesive SBO, NG decompression remains an important component of conservative management alongside bowel rest, intravenous fluids, electrolyte correction and close clinical monitoring.

Water-soluble contrast is primarily useful diagnostically. Passage of contrast into the colon helps predict successful non-operative resolution; convincing evidence for a true therapeutic effect is less certain.

A major change is occurring in postoperative care: routine prophylactic NG decompression after elective gastrointestinal surgery is increasingly discouraged.

ERAS philosophy: early oral intake + early mobilisation + fewer unnecessary tubes. Routine NG placement has not convincingly reduced anastomotic leak and may delay bowel recovery while increasing discomfort and some pulmonary complications.

Selective postoperative NG use remains appropriate for persistent vomiting, major gastric distension, clinically significant ileus, delayed gastric emptying or high aspiration risk.

Placement safety is critical: advance gently along the nasal floor and never force the tube against resistance. Air insufflation with auscultation is unreliable for confirming placement.

Before feeding or administering medication through an NG tube, correct intragastric positioning must be confirmed, commonly radiographically when required.

Prolonged suction can cause volume depletion, hypokalaemia and metabolic alkalosis; NG output, hydration and electrolytes therefore require active monitoring.

GastroAGI Bottom Line

The modern principle is no longer “NG tube by default.” It is “NG tube for a clear indication, safe placement, daily reassessment and removal at the earliest appropriate opportunity.”

Related Q&A

04

A Novel Oral Nonpeptide GLP-1 Agonist (HRS-7535) Improves Glycemic Control in Type 2 Diabetes: JAMA Network Open | August 2026

Introduction: Oral GLP-1 receptor agonists could overcome the inconvenience of injections, but currently available oral semaglutide requires specific fasting and administration conditions. HRS-7535 is a novel once-daily nonpeptide...

05

Nicotine Pouches: JAMA | July 2026

Introduction: Nicotine pouches are an increasingly popular smokeless oral nicotine product marketed as an alternative to cigarettes and other tobacco products. This review summarises their composition, health effects,...

06

Dopamine Beyond Reward. JAMA| May 2026

This review redefines dopamine (DA) signaling beyond its classical role in reward processing, positioning dopaminergic circuits as central regulators of feeding behavior, metabolic sensing, and energy homeostasis. The...

07

Gut–Heart Axis: Gut | May 2026

Introduction Atherosclerosis has traditionally been viewed as a lipid-driven disease. However, emerging evidence highlights a critical role of chronic inflammation and immune activation, with the gut microbiota now...

08

Bleeding Risk with Apixaban vs. Rivaroxaban: NEJM March 2026

Clinical Summary In this randomized international trial (COBRRA), investigators compared the bleeding risk of apixaban vs. rivaroxaban in patients with acute venous thromboembolism (VTE), including pulmonary embolism and...

09

ACG 2025

The American College of Gastroenterology (ACG) 2025 meeting is a prominent annual event where groundbreaking research, clinical studies, and advancements in gastroenterology are presented. At the ACG 2025...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer